top of page

Search Results

Results found for "GPCR therapeutics"

  • Precise druggability of the PTH type 1 receptor

    Class B G protein-coupled receptors (GPCRs) are notoriously difficult to target by small molecules because Using the parathyroid hormone type 1 receptor (PTHR) as a prototypic class B GPCR target, and a combination precise druggable sites and identify allosteric modulators of PTHR signaling that could be extended to GPCRs to expedite discoveries of small molecules as novel therapeutic candidates.

  • Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation

    bilayer creates is dynamic and interactive, becoming the foundation for many interactions involved in GPCR Understanding the interplay between GPCRs and β-arrestins and how this complex operates on the plasma Membrane phosphoinositides regulate GPCR-β-arrestin complex assembly and dynamics. Molecular mechanism of GPCR-mediated arrestin activation. Pharmacology & therapeutics, 89(2), 139–147. https://doi.org/10.1016/s0163-7258(00)00107-8

  • Coordinated transcriptomics and peptidomics of central nervous system identify neuropeptides and ...

    Neuropeptides and their specific receptors (primarily G protein-coupled receptors, GPCRs) regulate multiple A total of 41 neuropeptide GPCR genes belonging to three classes were also identified. These GPCRs and their probable ligands were predicted. expression patterns of these 98 genes in various larval tissues were evaluated using quantitative real-time PCR to determine physiological functions and pharmacological characterization of neuropeptides and their GPCRs

  • Do You Believe AI Could Accelerate Drug Discovery?

    G protein-coupled receptors (GPCRs) are major drug targets, yet their complex and dynamic structures By using machine learning, AF2 can accurately predict the 3D structures of GPCRs with atomic-level accuracy challenges is crucial to fully harness AI's potential in accelerating drug discovery and optimizing therapeutic

  • Fentanyl and Xylazine: Why Breathing Fails in Overdose

    Watch Episode 172 The Bigger Picture: GPCR Science Meets Public Health At its core, Catherine Demery’ For scientists, this means rethinking how we study GPCR-mediated respiratory depression. For scientists, they sharpen our understanding of how different GPCR systems interact to produce respiratory In other words, this is GPCR science with immediate, life-or-death consequences.

  • Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors

    Mutations in G protein-coupled receptors (GPCRs) underlie numerous diseases. Pharmacological chaperones are cell-permeant small molecules that engage nascent mutant GPCRs in the These findings aid in advancing the understanding of the effects of genetic mutations on GPCR function and provide a proof of therapeutic principle for FSHR pharmacological chaperones.

  • HDX-MS-optimized approach to characterize nanobodies as tools for biochemical and structural ...

    multiple immune signaling processes and is dependent on activation by Ras and G protein-coupled receptors (GPCRs that stimulated lipid kinase activity, block Ras activation, and specifically inhibited p101-mediated GPCR Overall, our work reveals insight into PI3Kγ regulation and identifies sites that may be exploited for therapeutic

  • Harnessing Deep Mutational Scanning for Enhanced Drug Discovery

    residues spans from the extracellular surface to the transmembrane area, linking with canonical class A GPCR activation motifs to initiate proton-sensing GPCRs. development of more personalised therapies tailored to the genetic makeup of individual patients, enhancing therapeutic that can drive the early stages of target and lead identification, combat drug resistance, and refine therapeutic

  • Chemokine receptor-targeted drug discovery: progress and challenges

    The therapeutic approaches mainly include small molecule inhibitors, as well as monoclonal antibodies Further difficulties arise from the existence of cross-reactivity with other GPCRs and differences in frequency of administration are particularly rigorous for this class, as the majority of potential therapeutic of chemokine receptors which are regulated by globular protein ligands, unlike most of the class A GPCRs Overall, the future potential lies in using different therapeutic modalities to modulate the stromal

  • Chronic itch: emerging treatments following new research concepts

    itch processing, the numerous mediators and receptors involved has led to a large variety of possible therapeutic However, many new targets, such as Mas-related GPCRs and unexpected new pathways need to be also explored

  • Target Residence Time: The Hidden Driver of In Vivo Efficacy

    Modeling tools to understand how restricted diffusion  in tissues like tumors slows offset and improves therapeutic And when receptors are dense (like GPCRs on membranes), this rebinding hits the collisional limit , where drug hiding in fat tissue may stay in the body for days, but if it never reaches the target site, the therapeutic

  • Beyond Clearance: The Strategic Power of Irreversible Drug Binding

    When a drug outlives its exposure , toxic interactions can be just as persistent as therapeutic ones. GPCR members save 50%+  with your Weekly News code. 👉  Join Terry’s Corner & Secure Your Spot for the Kenakin with your own enzyme or GPCR interaction puzzles.

  • Phenylalanine 193 in Extracellular Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin ...

    Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin Interaction G protein-coupled receptors (GPCRs The β2-adrenergic receptor (β2AR) is a prototypical and extensively studied GPCR that can provide insight into this aspect of GPCR signaling thanks to robust structural data and rich pharmacopeia. regulation that may contribute to biased signaling at GPCRs. We characterized the effects of extracellular loop mutations on agonist-promoted interactions of GPCRs

  • Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa

    These disorders are mainly related to the abnormalities in the rod G protein-coupled receptor (GPCR), Currently, there is no cure for RP, and the therapeutic options are limited.

  • Applications of Cryo-EM in small molecule and biologics drug design

    cryo-EM has enabled insights into important drug target families such as G protein-coupled receptors (GPCRs As a result, cryo-EM has begun to make major impacts in bringing critical therapeutics to market. In this review, we discuss recent instructive examples of impacts from cryo-EM in therapeutics design

  • Phospholipid Scrambling by G Protein-Coupled Receptors

    Unexpectedly, Class A G protein-coupled receptors (GPCRs), a large class of signaling proteins exemplified transbilayer lipid movement, conceptualized as the swiping of a credit card (lipid) through a card reader (GPCR Conformational changes that facilitate scrambling are distinct from those associated with GPCR signaling In this review, we discuss the physiological significance of GPCR scramblase activity and the modes of

  • The mouse cytomegalovirus G protein-coupled receptor homolog, M33, coordinates key features of ...

    all cytomegalovirus (CMV) genomes analysed to date is the presence of G protein-coupled receptors (GPCR IMPORTANCE G protein-coupled receptors (GPCRs) act as cell surface molecular "switches" which regulate All cytomegalovirus (CMV) genomes analysed to date possess GPCR homologs with phylogenetic evidence for The mouse CMV (MCMV) GPCR homolog, designated M33, is important for cell-associated virus spread and The signalling repertoire of M33 is distinct from cellular GPCRs and little is known of the relevance

  • Neuronal Gα subunits required for the control of response to polystyrene nanoparticles in the ...

    this study was to identify Gα proteins mediating function of neuronal G protein-coupled receptors (GPCRs Some neuronal GPCRs (such as GTR-1, DCAR-1, DOP-2, NPR-8, NPR-12, NPR-9, and DAF-37) functioned upstream of GOA-1, some neuronal GPCRs (such as DCAR-1, DOP-2, NPR-9, NPR-8, and DAF-37) functioned upstream of GSA-1, and some neuronal GPCRs (such as DOP-2, NPR-8, DAF-37, and DCAR-1) functioned upstream of GPA Our results provide clues for understanding the important function of GPCRs-Gα signaling cascade in the

  • A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9: Fluorescent Ligands ...

    allosteric binding site (IABS) has recently been identified at several G protein-coupled receptors (GPCRs To chemically induce CCR9 degradation, we then developed the first PROTAC targeting the IABS of GPCRs our CCR9-PROTAC is able to reduce CCR9 levels, thereby offering an unprecedented approach to modulate GPCR

  • The sixth transmembrane region of a pheromone G-protein coupled receptor, Map3, is implicated in ...

    molecular recognition of two peptidyl mating pheromones by their corresponding G-protein coupled receptors (GPCRs Here, we investigated the stringency of the two GPCRs, Mam2 and Map3, for their respective pheromones First, we switched GPCRs between S. pombe and the closely related species Schizosaccharomyces octosporus Thus, the differences in these two GPCRs might reflect the significantly distinct stringency/flexibility

  • Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and ...

    The G protein-coupled receptors (GPCRs) are the largest family of membrane receptors, with nearly 800 The recognition that GPCRs may physically interact with each other has led to the hypothesis that their Furthermore, the formation of GPCRs higher order oligomers provides the structural basis for organizing

  • A Model for the Signal Initiation Complex Between Arrestin-3 and the Src Family Kinase Fgr

    regulate a wide range of signaling events, most notably when bound to active G protein-coupled receptors (GPCRs Among the known effectors recruited by GPCR-bound arrestins are Src family kinases, which regulate cellular determined the crystal structure of the Fgr SH3 domain at 1.9 Å resolution and developed a model for the GPCR-arrestin

  • G protein-coupled receptor kinase 2 is essential to enable vasoconstrictor-mediated arterial ...

    vasoconstrictors, resulting in enhanced signalling through their cognate G protein-coupled receptors (GPCR Prolonged vasoconstrictor GPCR signalling increases arterial contraction and stimulates signalling pathways GPCR signalling through phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) promotes VSMC proliferation In VSMC, G protein-coupled receptor kinase 2 (GRK2) is known to regulate numerous vasoconstrictor GPCRs

  • In Vitro and In Silico Characterization of Kurarinone as a Dopamine D 1A Receptor Antagonist and ...

    Alterations in the expression and/or activity of brain G-protein-coupled receptors (GPCRs) such as dopamine Since studies have indicated that flavonoids can target brain GPCRs and provide neuroprotection via inhibition Functional GPCR assays unfolded the compound's antagonist behavior on D1R (IC50 42.1 ± 0.35 μM) and agonist

  • Lysophosphatidic Acid and Several Neurotransmitters Converge on Rho-Kinase 2 Signaling to Manage...

    Several neurotransmitters and neuromodulators, acting through G-protein-coupled receptors (GPCRs), fine-tune However, intracellular partners linking GPCRs to TASK1 modulation are not yet well-known. We hypothesized that isoform 2 of rho-kinase (ROCK2), acting as downstream GPCRs, mediates adjustment Furthermore, ROCK activity assays were performed to evaluate the ability of various physiological GPCR

  • Opioid Receptors and Protonation-Coupled Binding of Opioid Drugs

    Opioid receptors are G-protein-coupled receptors (GPCRs) part of cell signaling paths of direct interest typically have a protonated amino group that contributes to receptor binding, and the functioning of GPCRs

  • 4GPCRnet - International Symposium

    SEPTEMBER 26-29, 2022 (Leipzig, Germany)​ 4GPCRnet meeting bringing together four of the biggest GPCR Four of the biggest European networks on GPCR research (COST Actions Adher’n Rise and ERNEST plus DFG-funded

  • Chemogenetic stimulation of the G i pathway in astrocytes suppresses neuroinflammation

    Engineered G protein-coupled receptors (GPCRs) are commonly used in chemogenetics as designer receptors Although several GPCRs have been studied in astrocytes using a chemogenetic approach, the functional

  • Melatonin MT 2 receptor is expressed and potentiates contraction in human airway smooth muscle

    Numerous physiological effects of melatonin are mediated via its specific G protein-coupled receptors (GPCRs human and guinea pig airway smooth muscle and cultured human airway smooth muscle (HASM) cells by RT-PCR

  • Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall ...

    target for control of the fall webworm Hyphantria cunea Background: Insect G protein-coupled receptors (GPCRs HLGR2 is a typical GPCR and shows high structural and sequence similarity with other insect LGR2 proteins

bottom of page